MicroWash

MicroWash is a health care startup revolutionizing the sampling experience for respiratory illness diagnosis. Their slogan "Painless, fast and easy collection of COVID-19 nasal specimens and other respiratory illnesses" encapsulates their mission. The company's flagship product, the first nasal specimen collection device, aims to set a new gold standard for respiratory infection nasal sampling. Notably, it boasts surpassing the nasal swab in comfort, accuracy, stability, and accessibility. Founded in 2022 and headquartered in the United States, MicroWash recently received a $1.60MSeed Round investment on 20 February 2024 from prominent investors including Invest Nebraska, Bright Minds Capital Partners, Craig Aman, Anne Bueltel, Karen Aman, and Nicholas Lorenzo.

MicroWash has the potential to transform respiratory illness diagnostics and patient experience in a post-pandemic world. With its experienced leadership from diverse medical backgrounds and significant investments, the company is well-positioned to propel the evolution of specimen collection systems. As the demand for innovative and patient-friendly healthcare solutions continues to grow, MicroWash is poised to make a significant impact and attract further interest from both the industry and potential investors.